Profile data is unavailable for this security.
About the company
Bio-Thera Solutions, Ltd. is a China-based company mainly engaged in the research and development of innovative drugs and biosimilars. The Company is committed to the development of a new generation of antibody drugs to treat cancer, autoimmune diseases, cardiovascular diseases and other major diseases that endanger human life and health. The Company's main products include adalimumab BAT1406, bevacizumab BAT1706, BAT8001, tocilizumab BAT1806, batifaban BAT2094, BAT8003 and so on.
- Revenue in CNY (TTM)825.18m
- Net income in CNY-377.67m
- Incorporated2003
- Employees1.17k
- LocationBio-Thera Solutions Ltd5F, Building A6, No.11 Kaiyuan Avenue, SGUANGZHOU 510530ChinaCHN
- Phone+86 2 032203528
- Fax+86 2 032203218
- Websitehttps://www.bio-thera.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Beijing Kawin Technol Sha-hld Co Ltd | 1.42bn | 134.34m | 4.61bn | 584.00 | 33.01 | 2.48 | -- | 3.25 | 0.8175 | 0.8175 | 8.53 | 10.87 | 0.5736 | 1.80 | 3.27 | 2,431,971.00 | 6.49 | 5.31 | 8.52 | 6.76 | 81.80 | 86.02 | 11.31 | 8.10 | 2.91 | -- | 0.141 | 43.82 | 21.73 | 14.87 | 39.71 | 21.04 | 25.01 | -- |
| Beijing Sun-Novo Pharma Research Co Ltd | 1.16bn | 221.37m | 4.79bn | 1.39k | 21.62 | 4.23 | -- | 4.14 | 1.98 | 1.98 | 10.33 | 10.10 | 0.6079 | 35.95 | 1.77 | 844,377.10 | 11.25 | 12.99 | 18.76 | 21.70 | 53.30 | 53.93 | 18.50 | 21.34 | 1.86 | 29.92 | 0.3068 | 10.74 | 37.76 | 47.22 | 18.08 | 54.90 | 34.77 | -- |
| HitGen Inc | 423.87m | 52.55m | 5.08bn | 452.00 | 96.47 | 3.69 | -- | 11.99 | 0.1314 | 0.1314 | 1.06 | 3.44 | 0.248 | 7.10 | 4.55 | 937,755.30 | 2.99 | 4.63 | 3.16 | 5.10 | 51.23 | 58.89 | 12.05 | 20.66 | 16.15 | 38.23 | 0.1391 | 19.14 | 12.64 | 19.69 | 61.16 | -1.96 | -6.12 | -- |
| Shanghai Medicilon Inc | 984.17m | -276.79m | 5.11bn | 2.42k | -- | 2.17 | -- | 5.19 | -2.01 | -2.01 | 7.23 | 17.46 | 0.3029 | 6.90 | 1.27 | 378,525.60 | -8.52 | 9.34 | -10.66 | 11.73 | 0.6443 | 36.71 | -28.12 | 14.93 | 2.64 | -- | 0.1147 | 20.18 | -17.68 | 33.26 | -109.82 | -- | 23.60 | -- |
| GemPharmatech Co Ltd | 677.34m | 139.41m | 5.63bn | 1.51k | 40.00 | 2.64 | -- | 8.30 | 0.343 | 0.343 | 1.65 | 5.20 | 0.2703 | 4.54 | 2.06 | 449,761.40 | 5.56 | 9.45 | 6.39 | 11.13 | 63.04 | 70.21 | 20.58 | 28.16 | 4.74 | -- | 0.0509 | 14.68 | 20.45 | 63.48 | -3.48 | -- | 141.38 | -- |
| InventisBio Co Ltd | 77.51m | -348.02m | 6.17bn | 221.00 | -- | 3.56 | -- | 79.61 | -0.6064 | -0.6064 | 0.1346 | 3.01 | 0.0383 | -- | 0.5855 | 350,739.20 | -17.19 | -- | -18.36 | -- | 90.80 | -- | -448.98 | -- | -- | -- | 0.0138 | -- | -- | -- | 41.26 | -- | -- | -- |
| Bio-Thera Solutions Ltd | 825.18m | -377.67m | 9.12bn | 1.17k | -- | 10.77 | -- | 11.05 | -0.9121 | -0.9121 | 1.99 | 2.05 | 0.3533 | 1.00 | 6.83 | 707,092.40 | -16.17 | -23.62 | -26.76 | -30.81 | 69.81 | 79.76 | -45.77 | -106.72 | 0.716 | -27.47 | 0.4531 | -- | 54.86 | -- | 17.87 | -- | -3.78 | -- |
| Mabwell Shanghai Bioscience Co Ltd | 169.42m | -1.07bn | 9.54bn | 1.40k | -- | 4.98 | -- | 56.32 | -2.69 | -2.69 | 0.424 | 4.80 | 0.0379 | 0.089 | 9.74 | 113,628.50 | -24.10 | -37.61 | -30.74 | -45.95 | 90.50 | 81.54 | -636.41 | -2,112.26 | 1.25 | -41.98 | 0.5339 | -- | 361.03 | 27.88 | -10.28 | -- | 17.35 | -- |
| InnoCare Pharma Ltd | 898.92m | -375.51m | 12.73bn | 1.09k | -- | 3.55 | -- | 14.16 | -0.2325 | -0.2325 | 0.537 | 3.86 | 0.0922 | 1.32 | 3.73 | 825,457.90 | -4.02 | -- | -4.78 | -- | 84.50 | -- | -43.57 | -- | 7.65 | -- | 0.1547 | -- | 18.09 | -- | 28.80 | -- | -- | -- |
| Joinn Laboratories China Co Ltd | 2.12bn | -912.86k | 12.97bn | 2.59k | -- | 1.76 | -- | 6.10 | -0.0064 | -0.0064 | 2.82 | 10.68 | 0.2151 | 0.7714 | 7.32 | -- | -0.09 | 8.99 | -0.106 | 11.07 | 31.83 | 46.76 | -0.4184 | 32.01 | 2.85 | 1.25 | 0.0089 | 23.81 | 4.78 | 42.20 | -63.04 | 29.66 | 8.21 | 23.46 |
Data as of Sep 13 2024. Currency figures normalised to Bio-Thera Solutions Ltd's reporting currency: Chinese Yuan Renminbi CNY
4.39%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Penghua Fund Management Co., Ltd.as of 30 Jun 2024 | 4.21m | 1.03% |
| Zhong Ou Asset Management Co., Ltdas of 30 Jun 2024 | 3.59m | 0.88% |
| China Southern Asset Management Co., Ltd.as of 30 Jun 2024 | 2.38m | 0.58% |
| GF Fund Management Co., Ltd.as of 30 Jun 2024 | 1.46m | 0.36% |
| Yinhua Fund Management Co., Ltd.as of 30 Jun 2024 | 1.43m | 0.35% |
| Bosera Asset Management Co., Ltd.as of 30 Jun 2024 | 1.27m | 0.31% |
| The Vanguard Group, Inc.as of 06 Nov 2024 | 999.15k | 0.24% |
| China Universal Asset Management Co., Ltd.as of 30 Jun 2024 | 973.73k | 0.24% |
| Chang Xin Asset Management Co., Ltd.as of 30 Jun 2024 | 870.22k | 0.21% |
| China Asset Management Co., Ltd.as of 30 Jun 2024 | 762.79k | 0.19% |
More ▼
Data from 30 Jun 2024 - 11 Nov 2024Source: FactSet Research Systems Inc.
